Cardiology

Top Story

COMPARE: EES superior to PES at 5 years

July 29, 2015

Long-term data from the COMPARE trial demonstrate superiority of everolimus-eluting stents compared with paclitaxel-eluting stents in an all-comers population that underwent PCI.

Researchers aimed to determine whether benefits observed at 1 and 2 years with a second-generation everolimus-eluting stent (EES; Xience V, Abbott Vascular) compared with a second-generation paclitaxel-eluting stent (PES; Taxus Liberte, Boston Scientific) in earlier analyses of the COMPARE trial cohort were maintained through longer-term follow-up.

In the Journals

Lymphoma survivors face increased risk for cardiac problems after HSCT

July 29, 2015
Left ventricular systolic dysfunction and heart failure occurred more frequently than previously reported in adult survivors of lymphoma who underwent autologous…
In the Journals

Minimal, maximal pulmonary vein isolation yield similar freedom from AF

July 28, 2015
Freedom from atrial fibrillation occurred at similar rates between minimal and maximal pulmonary vein isolation strategies, according to results from the MINIMAX…
In the Journals

Hospitalization, death, cost drop among older Medicare beneficiaries

July 28, 2015
Between 1999 and 2013, Medicare fee-for-service beneficiaries aged 65 years and older had lower rates of mortality and hospitalization, as well as lower expenditures…
In the Journals

Ezetimibe plus statin linked to greater plaque regression in patients with PCI

July 28, 2015
Patients who underwent PCI had greater coronary plaque regression when assigned a statin plus ezetimibe compared with those assigned statin monotherapy, according to the…
More News Headlines »
CME
Cardiology Case Consults

The Patient With Idiopathic Pulmonary Fibrosis

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with idiopathic pulmonary fibrosis.
More »
Video
VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

July 17, 2015
PHILADELPHIA — In this video, Joseph Rossano, MD, MS, FAAP, FAAC, medical director of HF/transplantation at…
More »
CME
Oral Antiplatelet Therapy in a Patient with Acute Coronary Syndrome and Percutaneous Coronary Intervention

Case Study: Oral Antiplatelet Therapy in a Patient with ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, over 780,000 persons annually will experience an acute coronary syndrome…
More »
morganatic-roan